154 related articles for article (PubMed ID: 2413480)
21. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
[TBL] [Abstract][Full Text] [Related]
22. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.
Perrine SP; Olivieri NF; Faller DV; Vichinsky EP; Dover GJ; Ginder GD
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):67-71. PubMed ID: 7508690
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of A gamma and G gamma fetal hemoglobin mRNA levels by hydroxyurea and butyrate.
Xu J; Zimmer DB
Exp Hematol; 1998 Mar; 26(3):265-72. PubMed ID: 9502623
[TBL] [Abstract][Full Text] [Related]
24. Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction.
Pace BS; Zein S
Dev Dyn; 2006 Jul; 235(7):1727-37. PubMed ID: 16607652
[TBL] [Abstract][Full Text] [Related]
25. Regulation of fetal hemoglobin synthesis by cell cycle specific drugs.
Nathan DG
Prog Clin Biol Res; 1985; 191():475-500. PubMed ID: 2413483
[No Abstract] [Full Text] [Related]
26. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production.
Dover GJ; Humphries RK; Moore JG; Ley TJ; Young NS; Charache S; Nienhuis AW
Blood; 1986 Mar; 67(3):735-8. PubMed ID: 2418898
[TBL] [Abstract][Full Text] [Related]
27. Use of hydroxyurea in children with sickle cell disease: what comes next?
Ohene-Frempong K; Smith-Whitley K
Semin Hematol; 1997 Jul; 34(3 Suppl 3):30-41. PubMed ID: 9317199
[TBL] [Abstract][Full Text] [Related]
28. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea.
Letvin NL; Linch DC; Beardsley GP; McIntyre KW; Nathan DG
N Engl J Med; 1984 Apr; 310(14):869-73. PubMed ID: 6199670
[TBL] [Abstract][Full Text] [Related]
29. DNA hypo-methylating agents and sickle cell disease.
Saunthararajah Y; Lavelle D; DeSimone J
Br J Haematol; 2004 Sep; 126(5):629-36. PubMed ID: 15327513
[TBL] [Abstract][Full Text] [Related]
30. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
Watanapokasin R; Sanmund D; Winichagoon P; Muta K; Fucharoen S
Ann Hematol; 2006 Mar; 85(3):164-9. PubMed ID: 16389564
[TBL] [Abstract][Full Text] [Related]
31. Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells.
Keefer JR; Schneidereith TA; Mays A; Purvis SH; Dover GJ; Smith KD
Exp Hematol; 2006 Sep; 34(9):1151-61. PubMed ID: 16939808
[TBL] [Abstract][Full Text] [Related]
32. Disorders of the synthesis of human fetal hemoglobin.
Manca L; Masala B
IUBMB Life; 2008 Feb; 60(2):94-111. PubMed ID: 18379999
[TBL] [Abstract][Full Text] [Related]
33. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
Dover GJ; Charache S
Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
Stamatoyannopoulos JA; Nienhuis AW
Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
[TBL] [Abstract][Full Text] [Related]
35. 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia.
Ley TJ; DeSimone J; Anagnou NP; Keller GH; Humphries RK; Turner PH; Young NS; Keller P; Nienhuis AW
N Engl J Med; 1982 Dec; 307(24):1469-75. PubMed ID: 6183586
[TBL] [Abstract][Full Text] [Related]
36. Induction of fetal hemoglobin in the treatment of sickle cell disease.
Fathallah H; Atweh GF
Hematology Am Soc Hematol Educ Program; 2006; ():58-62. PubMed ID: 17124041
[TBL] [Abstract][Full Text] [Related]
37. Fetal hemoglobin levels in adults.
Rochette J; Craig JE; Thein SL
Blood Rev; 1994 Dec; 8(4):213-24. PubMed ID: 7534152
[TBL] [Abstract][Full Text] [Related]
38. Peripheral blood erythroid progenitors from patients with sickle cell anemia: HPLC separation of hemoglobins and the effect of a HbF switching factor.
Rosenblum BB; Strahler JR; Hanash SM; Whitten CF; Butkunas-Puskorius R; Roberts A
Prog Clin Biol Res; 1985; 191():397-410. PubMed ID: 2413478
[TBL] [Abstract][Full Text] [Related]
39. Monoterpenes as therapeutic candidates to induce fetal hemoglobin synthesis and up-regulation of gamma-globin gene: An in vitro and in vivo investigation.
Iftikhar F; Khan MBN; Musharraf SG
Eur J Pharmacol; 2021 Jan; 891():173700. PubMed ID: 33137331
[TBL] [Abstract][Full Text] [Related]
40. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
Rivers A; Vaitkus K; Jagadeeswaran R; Ruiz MA; Ibanez V; Ciceri F; Cavalcanti F; Molokie RE; Saunthararajah Y; Engel JD; DeSimone J; Lavelle D
Exp Hematol; 2018 Nov; 67():60-64.e2. PubMed ID: 30125603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
